Category Archives: News

Fluidda and Materialise announce partnership to develop personalized solutions for lung patients

Materialise invests 2.5mio EUR in Fluidda as part of a 4mio EUR Funding round. Fluidda announces a new phase in its collaboration with Materialise (NASDAQ: MTLS), to expand personalized treatment options in the respiratory care, building on its image based software. As part of the partnership, Materialise invests 2.5mio EUR in Fluidda and Wilfried Vancraen, founder and… Continue Reading

FLUIDDA at the ATS Conference, May 17-22, Dallas

Next month  Fluidda will exhibit at the annual American Thoracic Society International Conference ATS 2019 in Dallas, Texas. The ATS, founded in 1905, is the preeminent conference on pulmonary, critical care, and sleep medicine in the United States. It’s where ”today’s science meets tomorrow’s care.” One of the posters Fluidda will present is a study using the… Continue Reading

FRI technology used in PhD thesis on hyperinflation and COPD exacerbations

Last October, Wouter van Geffen, pulmonologist at the Medical Center Leeuwarden, The Netherlands, was awarded his PhD degree for this thesis titled: Hyperinflation and COPD exacerbations. In chapter four of this dissertation, the heterogeneity of acute COPD exacebations was investigated using Functional Respiratory Imaging (FRI). COPD exacerbations are a major burden to patients and yet… Continue Reading

CEO FLUIDDA now Member of advisory board Respiratory Innovation Summit (RIS)

Jan de Backer, MSc,PhD,MBA. CEO of FLUIDDA recently became member of the advisory board of the RIS. The Respiratory Innovation Summit unites the innovators, investors and clinicians who are leading the fight to create powerful new treatments for deadly and crippling diseases of the lungs and airways. Here you can find more information about the… Continue Reading

FLUIDDA moderates workshop on Functional Respiratory Imaging at the RDD 2019 congress, May 7-10, Estoril.

FLUIDDA moderates workshop on Functional Respiratory Imaging at the RDD 2019 congress, May 7-10, Estoril.

From May 7-10 the Respiratory Drug Delivery congress (RDD) will take place in Estoril, Portugal. This annual congress is focussed on the key-issues of developing inhaled therapies and novel inhalation devices for diseases of the upper- and lower airways. During this congress FLUIDDA N.V. organizes a workshop on Functional Respiratory Imaging (FRI), moderated by Cedric van… Continue Reading

FLUIDDA chairs a session on AI at the RIS in Dallas.

On Friday May 17, just before the start of the annual congress of the American Thoracic Society (ATS) in Dallas, the second meeting of the Respiratory Innovation summit (RIS) takes place. The RIS is intended to engage top investors, industry leaders and key opinion leaders to discuss key-topics in the translation of concepts to therapeutics,… Continue Reading

FLUIDDA chairs a session on AI at the RIS in Dallas.

Immunotherapy, lung tumors and blood vessels: what’s really happening?

In this case study we used the quantitative CT approach called Functional Respiratory Imaging (FRI) to assess the effect of immunotherapy on nodule volume and blood vessel volume. The female patient in this study was diagnosed with Non-Small Cell Lung Cancer (NSCLC) in the right upper lobe (RUL) and presented with no other respiratory disease. … Continue Reading

FLUIDDA at ERS2018 in Paris

For the next 5 days the FLUIDDA team will be present at the annual European Respiratory Society conference in Paris. We are looking forward to welcome you at booth 6 in block F. Here you can find out all the latest developments on how our Functional Respiratory Imaging solutions can assist in the development of… Continue Reading